Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120386) titled 'Clinical research on molecular probes targeting glypican 3 (GPC3)' on March 13.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: The First Affiliated Hospital of Guilin Medical University
Condition:
Malignant tumor
Intervention:
18F-GPC3P and 18F-FDG PET imaging group:Injection of 18F-GPC3P molecular probe
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-01
Target Sample Size: 18F-GPC3P and 18F-FDG PET imaging group:10;68Ga-GPC3P and 18F-FDG PET imaging group:10;
Countries of Recruitment:
China
To know more, visit https://www.c...